Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-APOD (21-189) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
APOD |
Gene ID: |
347 |
Uniprot ID: |
APOD_HUMAN |
Immunogen Region: |
21-189 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 21-189 of human APOD (NP_001638.1). |
Immunogen Sequence: |
QAFHLGKCPNPPVQENFDVN KYLGRWYEIEKIPTTFENGR CIQANYSLMENGKIKVLNQE LRADGTVNQIEGEATPVNLT EPAKLEVKFSWFMPSAPYWI LATDYENYALVYSCTCIIQL FHVDFAWILARNPNLPPETV DSLKNILTSNNIDVKKMTVT DQVNCPKLS |
Tissue Specificity | Expressed in liver, intestine, pancreas, kidney, placenta, adrenal, spleen, fetal brain tissue and tears. |
Post Translational Modifications | N-glycosylatd. N-glycan heterogeneity at Asn-65: Hex5HexNAc4 (major) and Hex6HexNAc5 (minor).at Asn-98: Hex5HexNAc4 (minor), dHex1Hex5HexNAc4 (major), dHex1Hex6HexNAc5 (minor) and dHex1Hex7HexNAc6 (minor). |
Function | APOD occurs in the macromolecular complex with lecithin-cholesterol acyltransferase. It is probably involved in the transport and binding of bilin. Appears to be able to transport a variety of ligands in a number of different contexts. |
Protein Name | Apolipoprotein DApo-DApod |
Database Links | Reactome: R-HSA-804914Reactome: R-HSA-9029569 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Apolipoprotein D antibodyAnti-Apo-D antibodyAnti-Apod antibodyAnti-APOD antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance